The use of maximum likelihood methods to estimate the risk of tuberculous infection and disease in a Canadian First Nations population

International Journal of Epidemiology

Volumn 33, Issue 3, 2004, Pages 477-484

  Clark, Michael ^a   Vynnycky, Emilia ^b  

^a HEALTH CANADA   (Canada)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Aboriginal; Canada; Epidemiology; Model; Tuberculosis

Indexed keywords

DISEASE TRANSMISSION; HEALTH RISK; INDIGENOUS POPULATION; TUBERCULOSIS;

ADULT; ARTICLE; BACTERIAL TRANSMISSION; CANADA; CHEMOTHERAPY; CHILD; CONTROLLED STUDY; DISEASE COURSE; GROUPS BY AGE; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; MAXIMUM LIKELIHOOD METHOD; MORTALITY; PREDICTION; PRIORITY JOURNAL; REINFECTION; RISK ASSESSMENT; STATISTICAL ANALYSIS; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

ADOLESCENT; ADULT; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INFANT; LIKELIHOOD FUNCTIONS; PREVALENCE; RECURRENCE; RISK FACTORS; SKIN TESTS; TUBERCULOSIS; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, PULMONARY;

BRITISH COLUMBIA; CANADA; NORTH AMERICA;

EID: 3242881594     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh001     Document Type: Article

References (39)

1. Health Canada. Tuberculosis in First Nations Communities, 1999. Ottawa: Minister of Public Works and Government Services, 2001.
2. FitzGerald JM, Wang L, Elwood RK. Tuberculosis: 13. Control of the disease among Aboriginal people in Canada. Can Med Assoc J 2000;162:351-55.
3. Clark M, Riben P, Nowgesic E. The association of housing density, isolation and tuberculosis in Canadian First Nations communities. Int J Epidemiol 2002;31:940-45.
4. Goldstone I, Albert R, Churchill K et al. HIV and injection drug use amongst First Nations in Vancouver: outcomes of care and neglect. Native Soc Work J 2000;3:145-63.
5. Bartlett RH. Reserve lands. In: Morse BW (ed.). Aboriginal Peoples and the Law: Indian, Metis, and Inuit Rights in Canada. Ottawa: Carleton University Press, 1991, pp. 467-578.
6. Department of Indian Affairs and Northern Development. Registered Indian Population by Sex and Residence 2000. Ottawa: Minister of Public Works and Government Services Canada, 2001.
7. Styblo K, Meijer J, Sutherland I. The transmission of tubercle bacilli: Its trend in a human population. Bull Int Union Tuberc 1969;42:5-104.
8. Sjögren I, Sutherland I. The risk of tuberculous infection in Sweden. Tubercle 1975;56:97-112.
9. de March-Ayuela P. Trend in tuberculous meningitis in Barcelona in children aged 0-4 years: correlation with the annual risk of tuberculous infection. Tuberc Lung Dis 1994;75:423-28.
10. Vynnycky E, Fine PEM. The annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901. Int J Tuberc Lung Dis 1997;1:389-96.
11. Brancker A, Enarson DA, Grzybowski S, Hershfield ES, Jeanes CWL. A statistical chronicle of tuberculosis in Canada: Part I. From the era of sanitorium treatment to the present. Stat Can Health Rep 1992;4:103-24.
12. Wherrett GJ. The Miracle of Empty Beds: A History of Tuberculosis in Canada. Toronto: University of Toronto Press, 1977.
13. Rieder H. Epidemiologic Basis of Tuberculosis Control. Paris: International Union Against Tuberculosis and Lung Disease, 1999.
14. Ades AE, Nokes DJ. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. Am J Epidemiol 1993;137:1022-34.
15. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-38.
16. Clayton D, Hills M. Statistical Models in Epidemiology. New York: Oxford University Press, 1993.
17. Cutts FT, Abebe A, Messele T et al. Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia. Epidemiol Infect 2000;124:467-79.
18. Sutherland I. On the risk of infection. Bull Int Union Tuberc Lung Dis 1991;66:189-91.
19. Sutherland I, Svandova E, Radhakrishna S. The development of clinical tuberculosis following infection with tubercle bacilli. Tubercle 1982;63:255-68.
20. Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet 1998;352:1886-91.
21. Medical Research Council. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull World Health Organ 1972;46:371-85.
22. Behr MA, Warren SA, Salamon H et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353:444-49.
23. Geduld J, Archibald C. National trends of AIDS and HIV in Canada. Can Comm Dis Rep 2000;26:193-201.
24. Heal G, Elwood RK, FitzGerald JM. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia. Int J Tuberc Lung Dis 1998;2:979-83.
25. Ferguson RG. Tuberculosis among the Indians of the Great Canadian Plains. London: Adlard & Son, 1929.
26. Advisory Committee for the Control and Prevention of Tuberculosis among the Indians. Proceedings of Advisory Committee for the Control and Prevention of Tuberculosis among the Indians Meeting at Ottawa; 30-31 May 1945; Ottawa, Canada.
27. Menzies R, Vissandjee B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145: 621-25.
28. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992;146:752-56.
29. Styblo K, Dankova D, Drapela J et al. Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia: Report for the first four years of the study (1961-1964). Bull World Health Organ 1967;37:819-74.
30. Long R, Jessamine P. Transmission and pathogenesis of tuberculosis. In: Long R (ed.). Canadian Tuberculosis Standards. 5th Edn. Ottawa: Canadian Lung Association, 2000, pp. 31-44.
31. Vynnycky E, Fine PEM. The natural history of tuberculosis: The implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997;119:183-201.
32. Wobeser W, To T, Hoeppner VH. The outcome of chemoprophylaxis on tuberculosis prevention in the Canadian Plains Indian. Clin Invest Med 1989;12:149-53.
33. Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991-1001.
34. Celia M, Greenwood T, Fujiwara TM et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMPI, in a large Aboriginal Canadian family. Am J Hum Genet 2000;67:405-16.
35. Hernández-Garduño E, Kunimoto D, Wang L et al. Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. Can Med Assoc J 2002;167:349-52.
36. van Rie A, Warren R, Richardson M et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. New Engl J Med 1999;341:1174-79.
37. FitzGerald JM, Black WA, Kunimoto D. Evaluation of non-HIV-related, drug-sensitive cluster outbreaks of tuberculosis with PCR-based DNA fingerprinting. Can Respir J 1996;3:317-21.
38. Wang L, Noertjojo K, Elwood RK, FitzGerald JM. Tuberculosis among aboriginal and nonaboriginal persons in British Columbia. Can Respir J 2000;7:151-57.
39. Broekmans JF. Tuberculosis control in low-prevalence countries. In: Reichman LB, Hershfield ES, (eds). Tuberculosis: A Comprehensive, International Approach. 2nd Edn. New York: Marcel Dekker, 2000, pp. 75-93.